MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ygyno.2024.07.685

Медицинская библиотека · Gynecologic oncology · 2024

Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes.

Vaz Jennifer, Piver Rachael, Brzezinska Bogna, Suhner Jessa, Sareddy Sneha, Vuppala Priyanka, Vernon Marlo, Xu Hongyan, Rungruang Bunja, Johnson Marian, Higgins Robert V, Ghamande Sharad, Richardson Katherine P, McIndoe Richard, Purohit Sharad, Mysona David

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

To determine if nutritional status effects response to immunotherapy in women with gynecologic malignancies.

METHODS

A retrospective chart review was conducted on gynecologic cancer patients who received immunotherapy at a single institution between 2015 and 2022. Immunotherapy included checkpoint inhibitors and tumor vaccines. The prognostic nutritional index (PNI) was calculated from serum albumin levels and total lymphocyte count. PNI values were determined at the beginning of treatment for each patient and assessed for their association with immunotherapy response. Disease control response (DCR) as an outcome of immunotherapy was defined as complete response, partial response, or stable disease.

RESULTS

One hundred and ninety-eight patients received immunotherapy (IT) between 2015 and 2022. The gynecological cancers treated were uterine (38%), cervix (32%), ovarian (25%), and vulvar or vaginal (4%) cancers. The mean PNI for responders was higher than the non-responder group (p < 0.05). The AUC value for PNI as a predictor of response was 49. A PNI value of 49 was 43% sensitive and 85% specific for predicting a DCR. In Cox proportional hazards analysis, after adjusting for ECOG score and the number of prior chemotherapy lines, severe malnutrition was associated with progression-free survival (PFS) (HR = 1.85, p = 0.08) and overall survival (OS) (HR = 3.82, p < 0.001). Patients with PNI < 49 were at a higher risk of IT failure (HR = 2.24, p = 0.0001) and subsequent death (HR = 2.84, p = 9 × 10-5).

CONCLUSIONS

PNI can be a prognostic marker to predict response rates of patients with gynecologic cancers treated with immunotherapy. Additional studies needed to understand the mechanistic role of malnutrition in immunotherapy response.

Для цитирования: Vaz Jennifer, Piver Rachael, Brzezinska Bogna, Suhner Jessa, Sareddy Sneha, Vuppala Priyanka, Vernon Marlo, Xu Hongyan, Rungruang Bunja, Johnson Marian, Higgins Robert V, Ghamande Sharad, Richardson Katherine P, McIndoe Richard, Purohit Sharad, Mysona David. Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes.. Gynecologic oncology. 2024. DOI: 10.1016/j.ygyno.2024.07.685.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.